Ventolin and Cromolyn sodium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ventolin (albuterol) and Cromolyn sodium (cromolyn sodium). Common drug interactions include renal cyst among females and alanine aminotransferase increased among males.

The phase IV clinical study analyzes what interactions people have when they take Ventolin and Cromolyn sodium. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Ventolin?

Ventolin has active ingredients of albuterol. It is often used in asthma. eHealthMe is studying from 51,849 Ventolin users. Check the latest studies of Ventolin.

What is Cromolyn sodium?

Cromolyn sodium has active ingredients of cromolyn sodium. It is often used in asthma. eHealthMe is studying from 3,022 Cromolyn sodium users. Check the latest studies of Cromolyn sodium.



On Jul, 17, 2026

16 people who take Ventolin and Cromolyn sodium together, and have interactions are studied.

Ventolin and Cromolyn sodium drug interactions.

What are the common drug interactions of Ventolin and Cromolyn Sodium, by gender? *:

female:

  1. Renal cyst (kidney cyst)
  2. Renal failure (kidney dysfunction)
  3. Renal failure acute (rapid kidney dysfunction)
  4. Respiratory failure (inadequate gas exchange by the respiratory system)
  5. Respiratory tract infection
  6. Rhonchi (abnormal breath sounds)
  7. Drug ineffective
  8. Arthralgia (joint pain)
  9. Erythema (redness of the skin)
  10. Haemorrhage (bleeding)

male:

  1. Alanine aminotransferase increased
  2. Aspartate aminotransferase increased
  3. Supraventricular tachycardia (rapid heart rhythm originating at or above the atrioventricular node)
  4. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  5. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  6. Blood alkaline phosphatase nos increased
  7. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
  8. Extrasystoles
  9. Infusion site swelling
  10. Overdose

What are the common drug interactions of Ventolin and Cromolyn Sodium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Alanine aminotransferase increased
  2. Anaphylactic reaction (serious allergic reaction)
  3. Aspartate aminotransferase increased
  4. Blood alkaline phosphatase nos increased
  5. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
  6. Dyspnoea (difficult or laboured respiration)
  7. Speech disorder

10-19:

n/a

20-29:

n/a

30-39:

  1. Haemorrhage (bleeding)
  2. Nephrolithiasis (calculi in the kidneys)
  3. Pain
  4. Urinary tract infection

40-49:

  1. Infusion site pain

50-59:

  1. Drug ineffective
  2. Rash pruritic (redness with itching)

60+:

  1. Drug ineffective
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Overdose
  4. Palpitations (feelings or sensations that your heart is pounding or racing)
  5. Pruritus (severe itching of the skin)
  6. Supraventricular tachycardia (rapid heart rhythm originating at or above the atrioventricular node)
  7. Syncope (loss of consciousness with an inability to maintain postural tone)
  8. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  9. Urticaria (rash of round, red welts on the skin that itch intensely)
  10. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)

What are the existing conditions these people have? *

  1. Type 2 Diabetes: 1 person, 6.25%
  2. Sinus Congestion (blockage of sinus): 1 person, 6.25%
  3. Pulmonary Embolism (blockage of the main artery of the lung): 1 person, 6.25%
  4. Pain: 1 person, 6.25%
  5. Osteoporosis (bones weak and more likely to break): 1 person, 6.25%
  6. Muscle Spasms (muscle contraction): 1 person, 6.25%
  7. Kidney Infection: 1 person, 6.25%
  8. Immunodeficiency Common Variable: 1 person, 6.25%
  9. High Blood Pressure: 1 person, 6.25%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Ventolin and Cromolyn sodium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ventolin and Cromolyn sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ventolin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cromolyn sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ventolin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cromolyn sodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on albuterol and cromolyn sodium (the active ingredients of Ventolin and Cromolyn sodium, respectively), and Ventolin and Cromolyn sodium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: